We are live on ! Find out more
AA

AlphaCentric Advisors Portfolio holdings

AUM $100M
This Fund
S&P 500
This Quarter Est. Return
+10.1%
1 Year Est. Return
–
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$101M
AUM Growth
+$3.77M
Cap. Flow
-$171K
Cap. Flow %
-0.17%
Top 10 Hldgs %
22.09%
Holding
226
New
42
Increased
62
Reduced
36
Closed
61

Top Buys

Rank Stock Value
1
NVAX icon
Novavax
NVAX
+$1.85M
2
CINC
CinCor Pharma, Inc. Common Stock
CINC
+$1.67M
3
TSVT
2seventy bio
TSVT
+$1.59M
4
ARQT icon
Arcutis Biotherapeutics
ARQT
+$1.37M
5
ADCT icon
ADC Therapeutics
ADCT
+$1.19M

Top Sells

Rank Stock Value
1
SHY icon
iShares 1-3 Year Treasury Bond ETF
SHY
+$12.8M
2
IWD icon
iShares Russell 1000 Value ETF
IWD
+$2.1M
3
RPV icon
Invesco S&P 500 Pure Value ETF
RPV
+$2.08M
4
WBA
Walgreens Boots Alliance
WBA
+$1.6M
5
SNY icon
Sanofi
SNY
+$1.56M

Sector Composition

Rank Sector Weight
1 Healthcare 56.8%
2 Real Estate 15.08%
3 Financials 8.32%
4 Energy 6.75%
5 Industrials 3.3%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
LEN icon
76
Lennar Class A
LEN
$20.2B
$440K 0.44%
5,028
– –
CTRA
77
DELISTED
Coterra Energy
CTRA
$433K 0.43%
17,606
+12,808
+267% +$353K
CI icon
78
Cigna
CI
$74.5B
$426K 0.42%
+1,287
New +$407K
MMD
79
MainStay MacKay DefinedTerm Municipal Opportunities Fund
MMD
$288M
$418K 0.41%
26,000
+3,500
+16% +$56.3K
ZYME icon
80
Zymeworks
ZYME
$1.78B
$413K 0.41%
+52,500
New +$369K
PSX icon
81
Phillips 66
PSX
$82.9B
$400K 0.4%
3,843
+2,501
+186% +$256K
INSM icon
82
Insmed
INSM
$23.5B
$400K 0.39%
+20,000
New +$387K
ITCI
83
DELISTED
Intra-Cellular Therapies Inc.
ITCI
$397K 0.39%
+7,500
New +$376K
TVTX icon
84
Travere Therapeutics
TVTX
$5.27B
$392K 0.39%
+18,640
New +$395K
FANG icon
85
Diamondback Energy
FANG
$55B
$392K 0.39%
2,863
+328
+13% +$47.9K
SAFE
86
Safehold
SAFE
$1.22B
$386K 0.38%
8,099
-2,300
-22% -$111K
DVAX
87
DELISTED
Dynavax Technologies
DVAX
$383K 0.38%
36,000
– –
OXY icon
88
Occidental Petroleum
OXY
$54.6B
$374K 0.37%
5,942
+975
+20% +$66.4K
INMD icon
89
InMode
INMD
$889M
$357K 0.35%
+10,000
New +$348K
PMF
90
DELISTED
PIMCO Municipal Income Fund
PMF
$335K 0.33%
32,150
+17,150
+114% +$177K
CVE icon
91
Cenovus Energy
CVE
$52.1B
$331K 0.33%
17,060
-1,063
-6% -$20.4K
MOS icon
92
The Mosaic Company
MOS
$7.03B
$323K 0.32%
7,358
+1,718
+30% +$85.1K
MDT icon
93
Medtronic
MDT
$106B
$311K 0.31%
+4,000
New +$324K
RBOT
94
DELISTED
Vicarious Surgical
RBOT
$303K 0.3%
5,000
+2,333
+87% +$217K
MRO
95
DELISTED
Marathon Oil Corporation
MRO
$302K 0.3%
+11,143
New +$323K
MBOT icon
96
Microbot Medical
MBOT
$118M
$301K 0.3%
100,000
– –
PXD
97
DELISTED
Pioneer Natural Resource Co.
PXD
$300K 0.3%
1,312
+247
+23% +$60.1K
GIS icon
98
General Mills
GIS
$20.3B
$296K 0.29%
3,536
+738
+26% +$60.1K
ADM icon
99
Archer Daniels Midland
ADM
$41.4B
$288K 0.28%
3,103
-392
-11% -$36.2K
AIG icon
100
American International
AIG
$42.7B
$288K 0.28%
4,547
-34
-0.7% -$1.98K
2 3
4
5 6

Similar funds

WCM
Weber Capital Management San Francisco, California $100M AUM
FCM
Fourier Capital Management Hong Kong $100M AUM
BIA
Baer Investment Advisory Corte Madera, California $100M AUM 23.87% 1-Year Est. Return
AGAM
Audent Global Asset Management West Hollywood, California $100M AUM 22.83% 1-Year Est. Return
E
Entelevest Coral Gables, Florida $100M AUM
HCM
Hicks Capital Management Columbus, Ohio $100M AUM 14.29% 1-Year Est. Return
AC
Arrow Capital Sydney, Australia $100M AUM 68.52% 1-Year Est. Return
OIS
OneAscent Investment Solutions Birmingham, Alabama $100M AUM 15.97% 1-Year Est. Return

AlphaCentric Advisors's Q4 2022 Portfolio in Review

As of Q4 2022, AlphaCentric Advisors held 226 positions worth $101M, up 3.9% from $97.4M the previous quarter. Its ten largest holdings account for 22% of the portfolio.

AlphaCentric Advisors's Q4 2022 filing shows 42 new, 62 increased, 36 reduced and 61 closed positions. Its largest new stake was Novavax: 105,000 shares worth $1.08M. The largest sale was iShares 1-3 Year Treasury Bond ETF, an estimated $12.8M.

By sector, the portfolio is most concentrated in Healthcare at 57% of assets, up from 44% a quarter earlier, followed by Real Estate and Financials.

  • AlphaCentric Advisors's largest Q4 2022 buy was Novavax: 105,000 shares worth $1.08M.
  • AlphaCentric Advisors added most to 2seventy bio in Q4 2022, an estimated $1.59M increase.
  • AlphaCentric Advisors's biggest Q4 2022 reduction was Walgreens Boots Alliance, cutting an estimated $1.6M.
  • AlphaCentric Advisors fully exited iShares 1-3 Year Treasury Bond ETF in Q4 2022, selling an estimated $12.8M.
  • AlphaCentric Advisors's ten largest holdings make up 22% of its $101M portfolio in Q4 2022.
  • AlphaCentric Advisors opened 42 new positions and closed 61 in Q4 2022.
  • AlphaCentric Advisors's portfolio value rose 3.9% quarter-over-quarter to $101M.

Based on AlphaCentric Advisors's 13F filing for Q4 2022, filed 7 Feb 2023.